NasdaqGS - Nasdaq Real Time Price
USD
AbCellera Biologics Inc. (ABCL)
13.64
+0.81
(+6.31%)
At close: October 28 at 4:00:01 PM EDT
13.48
-0.16
(-1.17%)
Pre-Market: 5:50:21 AM EDT
Trade ABCL on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreAnalyst Insights
Top Analyst
Stifel
60/100
Analyst Price Targets
Analyst Recommendations
-
Strong Buy
-
Buy
-
Hold
-
Underperform
-
Sell
Latest Rating
Date
10/12/2026
Analyst
UBS
Rating Action
Initiated
Rating
Buy
Price Action
Announces
Price Target
18
Top Analysts
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more| Analyst
|
Overall Score
|
Direction Score
|
Price Score
|
Latest Rating
|
Price Target
|
Date
|
|---|---|---|---|---|---|---|
|
Stifel
|
60 | 40 | 96 | Buy
|
9 | 2026-08-06 |
|
Benchmark
|
40 | 27 | 30 | Buy
|
11 | 2026-07-08 |
Rows per page
1-2 of 2
Upgrades & Downgrades
| Initiated | UBS: Buy | 10/12/2026 |
| Initiated | JP Morgan: Overweight | 9/29/2026 |
| Maintains | Truist Securities: Buy to Buy | 8/11/2026 |
| Maintains | Stifel: Buy to Buy | 8/6/2026 |
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 8/6/2026 |
| Upgrade | Benchmark: Hold to Buy | 7/7/2026 |
